Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Current Liabilities (2016 - 2025)

Prestige Consumer Healthcare has reported Total Current Liabilities over the past 15 years, most recently at $139.6 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 36.09% year-over-year to $139.6 million; the TTM value through Dec 2025 reached $139.6 million, up 36.09%, while the annual FY2025 figure was $106.6 million, 8.91% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $139.6 million at Prestige Consumer Healthcare, up from $134.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $160.7 million in Q1 2023 and troughed at $102.5 million in Q4 2024.
  • A 5-year average of $131.9 million and a median of $132.2 million in 2023 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: fell 27.17% in 2024 and later soared 36.09% in 2025.
  • Year by year, Total Current Liabilities stood at $135.1 million in 2021, then grew by 18.54% to $160.2 million in 2022, then fell by 20.44% to $127.4 million in 2023, then decreased by 19.53% to $102.5 million in 2024, then soared by 36.09% to $139.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for PBH at $139.6 million in Q4 2025, $134.6 million in Q3 2025, and $109.7 million in Q2 2025.